IP Library Granted Patent US 11,273,175
Granted Patent B2
US 11,273,175 · App. 16/626,194 · Granted Mar 15, 2022

Method for treating fibrillar collagenous conditions

Inventor: Matthew F. Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
A61K33/18A61K47/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,273,175
App. No.
16/626,194
Granted
Mar 15, 2022
Kind
B2
Abstract

A topical composition can be used to treat or inhibit onset of fibrillar collagenous growths, including but not limited to keloids. The composition includes elemental iodine carried in a non-migratory vehicle. Application of the composition can result in a significant reduction in the size of such a growth or, if applied to an area of skin susceptible to such a growth, inhibit the onset thereof.

Claims (5)

1. A process for reducing the size of a fibrillar collagenous growth, said fibrillar collagenous growth having an initial volume, said process consisting of (a) providing to a human in need thereof a treating composition that consists of an iodophor carried in a water soluble modified starch that is the reaction product of dextrin and epichlorohydrin and (b) instructing said human to apply said composition to said growth for up to at least two days.

2. The process of claim 1 wherein said iodophor is a macromolecule-thickened povidone-iodine.

3. The process of claim 1 wherein said fibrillar collagenous growth initial volume is reduced by at least 50%.

4. The process of claim 3 wherein said fibrillar collagenous growth initial volume is reduced by at least 67%.

5. The process of claim 4 wherein said fibrillar collagenous growth initial volume is reduced by at least 75%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (2)
Provisional Application 62525097 · Jun 26, 2017
Related Publication 20200113936A1 · Apr 16, 2020